NeoGenomics Appoints David Eberhard MD, PhD as Chief Medical Officer of Inivata Liquid Biopsy Subsidiary
Press Release
Read More
Detection of CCND1 Overexpression By RNA-Seq from TNA Samples As a Surrogate for t(11:14) Translocation Traditionally Measured By FISH in Multiple Myeloma Patients for Improved Patient Care
Literature
Read More
A Novel NGS-Based Simultaneous Detection of DNA and RNA Biomarkers Using Total Nucleic Acid (TNA) for Acute Lymphocytic Leukemia (ALL)
Literature
Read More
Comparison of low Ki67 scores (<5 or <10%) on core biopsy versus low 21-gene assay Recurrence Scores (<26) on surgical specimens in node-negative, HR+ breast cancer patients over age 50 years
Literature
Read More
NeoGenomics to Leverage Thermo Fisher Scientific’s Ion Torrent Genexus System in Upcoming Phase 1 Study for Myeloid Cancers
Press Release
Read More
Detection of early-stage breast cancer recurrence using a personalised liquid biopsy-based sequencing approach
Literature
Read More
Peripheral immune subsets and circulating tumor DNA (ctDNA) in patients (pts) with residual triple negative breast cancer (TNBC) treated with adjuvant immunotherapy and/or chemotherapy (chemo): The OXEL study
Literature
Read More